Abstract
Transfusion-related sepsis is both the oldest recognized and most common transfusion-associated infectious risk. Despite an increased awareness and recognition of this problem, particularly with room-temperature stored platelets, strategies to prevent or reduce the occurrence of this problem have proved daunting. With the recent FDA approval of culture methods for platelet bacterial testing and the promulgation of accreditation standards by the College of American Pathologists and American Association of Blood Banks to limit and detect platelet bacterial contamination, it is anticipated that the frequency of this problem will now begin to diminish. As methods to reduce and/or inactivate pathogens emerge, it is hoped that transfusion-related sepsis will essentially disappear.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
